These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12052588)

  • 1. Second-trimester genetic sonography in patients with advanced maternal age and normal triple screen.
    Vintzileos AM; Guzman ER; Smulian JC; Yeo L; Scorza WE; Knuppel RA
    Obstet Gynecol; 2002 Jun; 99(6):993-5. PubMed ID: 12052588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down syndrome risk estimation after normal genetic sonography.
    Vintzileos AM; Guzman ER; Smulian JC; Yeo L; Scorza WE; Knuppel RA
    Am J Obstet Gynecol; 2002 Nov; 187(5):1226-9. PubMed ID: 12439509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is genetic ultrasound cost-effective?
    DeVore GR
    Semin Perinatol; 2003 Apr; 27(2):173-82. PubMed ID: 12769203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21.
    Vintzileos AM; Campbell WA; Rodis JF; Guzman ER; Smulian JC; Knuppel RA
    Obstet Gynecol; 1996 Jun; 87(6):948-52. PubMed ID: 8649704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21.
    Vintzileos AM; Guzman ER; Smulian JC; Day-Salvatore DL; Knuppel RA
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1045-8. PubMed ID: 10561615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome.
    Yeo L; Vintzileos AM
    Semin Perinatol; 2003 Apr; 27(2):152-9. PubMed ID: 12769201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal midtrimester (17-20 weeks) genetic sonogram decreases amniocentesis rate in a high-risk population.
    Pinette MG; Garrett J; Salvo A; Blackstone J; Pinette SG; Boutin N; Cartin A
    J Ultrasound Med; 2001 Jun; 20(6):639-44. PubMed ID: 11400938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic sonography: an option for women of advanced maternal age with negative triple-marker maternal serum screening results.
    DeVore GR; Romero R
    J Ultrasound Med; 2003 Nov; 22(11):1191-9. PubMed ID: 14620890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
    Nyberg DA; Luthy DA; Cheng EY; Sheley RC; Resta RG; Williams MA
    Am J Obstet Gynecol; 1995 Oct; 173(4):1030-5. PubMed ID: 7485289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester genetic sonography after first-trimester combined screening for trisomy 21.
    Wax JR; Pinette MG; Cartin A; Blackstone J
    J Ultrasound Med; 2009 Mar; 28(3):321-5. PubMed ID: 19244068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ultrasound in screening for fetal Down syndrome.
    Egan JF
    Curr Womens Health Rep; 2002 Feb; 2(1):52-8. PubMed ID: 12112983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of genetic sonography and maternal serum triple-marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years.
    DeVore GR; Romero R
    J Ultrasound Med; 2001 Jun; 20(6):645-54. PubMed ID: 11400939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound screening of fetuses at increased risk for Down syndrome: how many missed diagnoses?
    Caughey AB; Lyell DJ; Washington AE; Filly RA; Norton ME
    Prenat Diagn; 2006 Jan; 26(1):22-7. PubMed ID: 16378329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing.
    Benn PA
    Clin Chim Acta; 2002 Sep; 323(1-2):1-16. PubMed ID: 12135803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humeral shortening in second-trimester fetuses with Down syndrome.
    Benacerraf BR; Neuberg D; Frigoletto FD
    Obstet Gynecol; 1991 Feb; 77(2):223-7. PubMed ID: 1824870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of second-trimester ultrasound markers for Down syndrome in pregnant women of advanced maternal age.
    Rumi Kataguiri M; Araujo Júnior E; Silva Bussamra LC; Nardozza LM; Fernandes Moron A
    J Pregnancy; 2014; 2014():785730. PubMed ID: 24795825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.